Onderzoeker
Sylvie Rottey
- Disciplines:Kankertherapie, Oncologie niet elders geclassificeerd, Kankerbiologie
Affiliaties
- Vakgroep Fundamentele en Toegepaste Medische Wetenschappen (Departement)
Lid
Vanaf1 okt 2018 → Heden - Vakgroep Farmacologie (Departement)
Lid
Vanaf1 okt 2008 → 30 sep 2018
Projecten
1 - 2 of 2
- Universeel, kosten-effectief open-source technologieplatform voor lichaamsvloeistof-biopsie met hoge gevoeligheid, gebaseerd op het profileren van het methyloom van circulerend DNA.Vanaf1 jan 2024 → HedenFinanciering: BOF - projecten
- Predictie van immuuntherapie response en toxiciteit in melanoom, nier- en longkanker door een transcriptoom gebaseerde immuun profilering.Vanaf1 nov 2021 → HedenFinanciering: FWO mandaten
Publicaties
41 - 50 van 103
- Surgical safety of cytoreductive nephrectomy following sunitinib : results from the multicentre, randomised controlled trial of immediate versus deferred nephrectomy (SURTIME)(2019)
Auteurs: Roderick Emile De Bruijn, Peter Mulders, Michael A Jewett, John Wagstaff, Johan V Van Thienen, Christian U Blank, Roland Van Velthoven, Lori Wood, Harm E van Melick, Maureen J Aarts, et al.
Pagina's: 437 - 440 - Cabazitaxel versus abiraterone or enzalutamide in metastatic prostate cancer(2019)
Auteurs: Ronald de Wit, Johann de Bono, Cora N. Sternberg, Karim Fizazi, Bertrand Tombal, Christian Wülfing, Gero Kramer, Jean-Christophe Eymard, Aristotelis Bamias, Joan Carles, et al.
Pagina's: 2506 - 2518 - Phase 1 study evaluating the association of the cyclin-dependent kinase 4/6 inhibitor ribociclib and cetuximab in recurrent/metastatic p16-negative squamous cell carcinoma of the head and neck(2019)
Auteurs: Emmanuel Seront, Sandra Schmitz, Matthias Papier, Aline van Maanen, Stéphanie Henry, Christophe Lonchay, Sylvie Rottey, Gabrielle van Caloen, Jean-Pascal Machiels
- Mobile health technology captures 'in-house' data on the outside : an assessment with pharmacological intervention(2019)Volume: 105
Auteurs: G Bhatia, Q Huang, T Crumley, C Walters, L Cluckers, I Heirman, L Mixson, Sylvie Rottey, M Cantor, C Benko, et al.
Pagina's: S73 - S73 - Comparison of immediate vs deferred cytoreductive nephrectomy in patients with synchronous metastatic renal cell carcinoma receiving sunitinib : the SURTIME randomized clinical trial(2019)
Auteurs: Axel Bex, Peter Mulders, Michael Jewett, John Wagstaff, Johannes V van Thienen, Christian U Blank, Roland van Velthoven, Maria del Pilar Laguna, Lori Wood, Harm HE van Melick, et al.
Pagina's: 164 - 170 - A phase II study of monalizumab in patients with recurrent/metastatic (RM) squamous cell carcinoma of the head and neck (SCCHN) : results of the I1 cohort of the EORTC-HNCG-1559 trial (UPSTREAM)(2019)Volume: 30
Auteurs: R Galot, C Le Tourneau, E Saada-Bouzid, A Daste, C Even, PR Debruyne, S Henry, S Zanetta, A Rutten, LF Licitra, et al.
Pagina's: v449 - v450 - Prostate protein n-glycosylation profiling by means of DNA sequencer-assisted fluorophore-assisted carbohydrate electrophoresis(2019)Edition: 2nd ed.Series: Methods in Molecular Biology
Auteurs: Tijl Vermassen, Nico Callewaert, Sylvie Rottey, Joris Delanghe, Terry M Phillips
Pagina's: 235 - 250 - European Federation for Exploratory Medicines Development Lyon Conference 2019 : the changing landscape of early medicines development : be prepared(2019)
Auteurs: Tim Hardman, Henri Caplain, Sylvie Rottey, Desiree Douglas, Steffan Stringer, Hildegard Sourgens
- N-Linked glycosylation and near-infrared spectroscopy in the diagnosis of prostate cancer(2019)
Auteurs: Tijl Vermassen, Sander De Bruyne, Jonas Himpe, Nicolaas Lumen, Nico Callewaert, Sylvie Rottey, Joris Delanghe
- Phase Ib study of talimogene laherparepvec (T-VEC) injection into liver metastases (LMs) in combination with intravenous (IV) atezolizumab in patients (pts) with metastatic triple negative breast cancer (TNBC) or colorectal cancer (CRC).(2019)Volume: 37
Auteurs: J. Randolph Hecht, Arlene Chan, Miguel Martin, Nicolas Mach, Sara A. Hurvitz, Sylvie Rottey, Uwe Pelzer, Chunxu Liu, Emily Chan
Aantal pagina's: 1